Detalhe da pesquisa
1.
Statistical Considerations and Software for Designing Sequential, Multiple Assignment, Randomized Trials (SMART) with a Survival Final Endpoint.
J Biopharm Stat
; : 1-14, 2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434437
2.
KDR genetic predictor of toxicities induced by sorafenib and regorafenib.
Pharmacogenomics J
; 22(5-6): 251-257, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484400
3.
Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma.
J Neurooncol
; 158(3): 323-330, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583721
4.
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.
Cancer Res Commun
; 4(3): 682-690, 2024 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363156
5.
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention.
J Clin Oncol
; 40(32): 3709-3718, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696629
6.
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
Blood Adv
; 6(14): 4085-4092, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838753
7.
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer.
JNCI Cancer Spectr
; 5(5)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485815
8.
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).
Blood Adv
; 5(13): 2775-2787, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251414